ArticleInternational journal of clinical oncology2024

Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab.

Takayuki Nakayama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.